Decreased production of interleukin-12 and interferon-? is associated with renal involvement in systemic lupus erythematosus

References

• Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145–73.
   PubMed Web of Science ®Google Scholar
• Rapoport MJ, Jaramillo A, Zipris D, et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1994;178:87–99.
   Google Scholar
• Racke MK, Bonomo A, Scott DE, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994;180:1961–6.
   PubMed Web of Science ®Google Scholar
• Nicholson LB, Greer JM, Sobel RA, Lees MB, Kuchroo VK. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 1995;3:397–405.
   Google Scholar
• Wong WM, Vakis SA, Ayre KR, et al. Rheumatoid arthritis T cells produce Thl cytokines in response to stimulation with a novel trispecific antibody directed against CD2, CD3, and CD28. Scand J Rheumatol 2000;29:282–7.
   PubMed Web of Science ®Google Scholar
• Llorente L, Richaud-Patin Y, Rior R, et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus: A potential mechanism of B lymphocyte hyperactivity and auto-immunity. Arthritis Rheum 1994;37:1647–55.
   PubMed Web of Science ®Google Scholar
• Funauchi M, Ikoma S, Enomoto H, Horiuchi A. Decreased Thl-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 1998;27:219–24
   PubMed Web of Science ®Google Scholar
• Richard-Patin Y, Alcocer-Varela J, Llorente L. High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev Invest Clin 1995;47:267–72.
   PubMedGoogle Scholar
• Horwitz DA, Jacob C. The cytokine network in the pathogen- esis of systemic lupus erythematosus and possible therapeutic implications. Springer Semin Immunopathol 1994;16:181–200.
   PubMed Web of Science ®Google Scholar
• Horwitz DA, Gray JD, Behrendsen SC, et al. Decreased production of interleukin-12 and other Th 1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 1998;41:838–44.
   PubMed Web of Science ®Google Scholar
• Kim T, Kanayama Y, Negoro N, Okamura M, Takeda T, Inoue T. Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 1987;70:562–9.
   PubMed Web of Science ®Google Scholar
• Tokano Y, Morimoto S, Kaneko H, et al. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) - relation to Th 1- and Th2-derived cytokines. Clin Exp Immunol. 1999;116:169–73.
   PubMed Web of Science ®Google Scholar
• Jacob CO, van der M eide PH, McDevitt HO. In vivo treatment of (NZB X NZW) Fl lupus-like nephritis with monoclonal antibody to y interferon. J Exp Med 1987: 166:798–803.
   Google Scholar
• Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;35:630–40.
   Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron K, Chang CH, the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630–40.
   PubMed Web of Science ®Google Scholar
• Kalke S, Balakrishanan C, Mangat G, Mittal G, Kumar N, Joshi VR. Echocardiography in systemic lupus erythematosus. Lupus 1998;7:540–4.
   PubMedGoogle Scholar
• Toubi E, Rosner I, Rozenbaum M, Kessel A, Golan TD. The benefit of combining hydroxychloroquine with quinacrine in the treatment of SLE patients. Lupus 2000;9:92–5.
   Google Scholar
• Hirokawa M, Gray JD, Takahashi T, Horwitz DA. Human resting B lymphocytes serve as accessory cells for anti-CD2 induced T cell activation. J Immunol 1992;149:1859–66.
   PubMedGoogle Scholar
• Kim WU, Cho ML, Kim SI, et al. Divergent effect of cyclosporin on Thl/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis. J Rheumatol 2000;27:324–31.
   PubMed Web of Science ®Google Scholar
• Peng SL, Moslehi J, Craft J. Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest 1997;99: 1936–46.
   Google Scholar
• Segal R, Bermas BL, Dayan M, Kalush F, Sheaer GM, Mozes E. Kinetics of cytokine production in experimental systemic lupus erythematosus. J Immunol 1997;158:3009–16.
   PubMedGoogle Scholar
• Akahoshi M, Nakashima H, Tanaka Y, et al. Thl/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 1999;42:1644–8.
   PubMed Web of Science ®Google Scholar
• Jung T, Schauer U, Hausser C, Neumann C, Reiger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993;159:197–207.
   Google Scholar
• Maino VC, Picker U. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry 1998;34:207–15.
   PubMedGoogle Scholar
• Hsieh CS, Heimberger AB, Gold J, O'Garra A, Murphy K. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an a:/3 T-cell receptor transgenic system. Proc Natl Acad Sci USA 1992;89: 6065–9.
   Google Scholar
• Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of Th 1 CD4 + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260: 547–9.
   Google Scholar
• Hagiwara E, Gourley MF, Lee S, Klinman DK. Disease severity in patients with systemic lupus erythematosus correl-ated with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum 1996;39:379–85.
   PubMed Web of Science ®Google Scholar
• Blotta MH, DeKruyff RH, U met su DT. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4 + lymphocytes. J Immunol 1997;158:5589–95.
   Google Scholar
• Gazzinelli RT, Heiny S, Wynn TA, Wolf S, Sher A. Interleukin 12 is required for the T lymphocyte-independent induction of interferon-y by an intracellular parasite and induces resis-tance in T cell-deficient host. Proc Natl Acad Sci USA 1993;90: 6115–9.
   Google Scholar
• Germann T, Gately MK, Schoenhaut DS, et al. Interleukin 12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Thl) but not on Th2 cells. Eur J Immunol 1993;23:1762–70.
   PubMed Web of Science ®Google Scholar
• Nastala CL, Edington HD, McKinney TG, et al. Recombinant IL-12 administration induces tumor regression in association with INF-y production. J Immunol 1994;153:1676–706.
   Google Scholar
• D'Andrea A, Aste-Amezega M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon y production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041–8.
   PubMed Web of Science ®Google Scholar
• Kiniwa M, Gately M, Gubler U, Chizzonite R, Fargeas C, Delespesse G. Recombinant interleukin-12 suppresses the syn-thesis of IgE by interleukin-4 stimulated human lymphocytes. J Clin Invest 1992;90:262–6.
   PubMed Web of Science ®Google Scholar
• Liu TF, Jones BM. Impaired production of IL-12 in systemic lupus erythematosus. II: IL-12 production iin vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE. Cytokine 1998;10: 148–53.
   Google Scholar
• Houssiau FA, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer JP, Renauld JC. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995;4:393–5.
   PubMed Web of Science ®Google Scholar
• Park YB, Lee SK, Kim DS, Lee J, Lee CH, Song CH. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 1998;16:283–8.
   PubMed Web of Science ®Google Scholar
• Funauchi M, Yu H, Sugiyama M, et al. Increased interleukin-4 production by NK T cells in systemic lupus erythematosus. Clin Immunol 1999;92:197–202.
   PubMedGoogle Scholar